

















608Effects of Sublethal Irradiation on Patterns of
Engraftment after Murine Bone Marrow
Transplantation
Jacob Andrade,1 Shundi Ge,2 Goar Symbatyan,3
Michael S. Rosol,3 Arthur J. Olch,4 Gay M. Crooks2Attempts to reduce the toxicity of hematopoietic stem cell transplantation have led to the use of various immu-
nosuppressive, yet nonmyeloablative preparative regimens that often include low-dose irradiation. To deter-
mine the effects of low-dose irradiation on the dynamics of donor cell engraftment after bone marrow
transplantation (BMT), we coupled standard endpoint flow cytometric analysis with in vivo longitudinal biolu-
minescence imaging performed throughout the early (\10 days) and late (days 10-90) post-BMT periods. To
exclude the contribution of irradiation on reducing immunologic rejection, severely immune-deficient mice
were chosen as recipients of allogeneic bone marrow. Flow cytometric analysis showed that sublethal doses
of total body irradiation (TBI) significantly increased long-term (14 weeks) donor chimerism in the bone
marrow compared with nonirradiated recipients (P \ .05). Bioluminescence imaging demonstrated that
the effect of TBI (P\ .001) on chimerism occurred only after the first 7 days post-BMT. Flow cytometric
analysis on day 3 showed no increase in the number of donor cells in irradiated bone marrow, confirming
that sublethal irradiation does not enhance marrow chimerism early after transplantation. Local irradiation
also significantly increased late (but not early) donor chimerism in the irradiated limb. Intrafemoral injection
of donor cells provided efficient early chimerism in the injected limb, but long-term systemic donor chimerism
was highest with i.v. administration (P\.05). Overall, the combination of TBI and i.v. administration of donor
cells provided the highest levels of long-term donor chimerism in the marrow space. These findings suggest
that the major effect of sublethal irradiation is to enhance long-term donor chimerism by inducing proliferative
signals after the initial phase of homing.
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donor cells. The toxicity associatedwith high-dose radi-
ation and chemotherapy excludes many patients from
receiving this necessary treatment, however.High levels
of bone marrow chimerism also have been achieved us-
ing nonmyeloablative conditioning regimens that focus
mostly on immune suppression [1-3]. Several rodent
models of nonmyeloablative BMT have demonstrated
that engraftment can be enhanced by increasing the
donor cell dose [4], changing the route of cell adminis-
tration [5], or increasing immunologic suppression to
prevent rejection [6,7].
Most clinical nonmyeloablative preparative regi-
mens include low-dose irradiation [8]. The mechanism
through which low-dose radiation acts to improve
engraftment remains controversial. Although lethal
irradiation is believed to create ‘‘space’’ in the stem
cell niche, the most primitive hematopoietic stem cells
are relatively resistant to irradiation [9].Thus, low-dose
irradiation is often considered to aid engraftment
through lymphoablation. An intriguing finding using a
Biol Blood Marrow Transplant 17:608-619, 2011 609Sublethal Irradiation and Engraftment Patternsmurine congenic transplantation model was that high-
dose irradiation of a local area of marrow increased en-
graftment both locally and at distal sites, suggesting
that at least high doses of irradiation enhance engraft-
ment independent of immunologic barriers [10].
The central goal of the present work was to assess
the effect of sublethal irradiation provided as either to-
tal body irradiation (TBI) or local irradiation, on the
process of engraftment. Severely immune-deficient
mice (nonobese diabetic [NOD] severe combined im-
mune-deficient [SCID] IL-2Rgnull, also known as
NSG) were used as recipients to exclude the contribu-
tion of irradiation on immunologic rejection of alloge-
neic bone marrow. In addition to absent T and B cell
development from the SCID mutation, the NODmu-
tation results in abnormal macrophage and dendritic
cell function, and the IL2Rg null mutation results in
natural killer (NK) cell deficiency. Thus, severe defects
exist in both the adaptive and innate immune systems
of NSG mice [11].
Engraftment is a process resulting from a combina-
tion of early homing and lodging of donor stem cells to
the recipient endosteal niche, with subsequent prolifera-
tion and redistribution throughout the marrow spaces
[12-14]. Engraftment can be measured in vivo by
quantifying the number of donor cells circulating in
the recipient’s peripheral blood. But this method does
not accurately determine the chimerism of donor
hematopoietic stem cells in the recipient bone marrow
and is limited by the number of repeat bleeds from
a single animal. The standard quantitative measurement
of donor chimerism in the marrow cavity uses flow
cytometric analysis of cells isolated from the bone
marrow of euthanized animals. Although very sensitive,
this type of analysis is poorly suited for longitudinal
studies of engraftment patterns. In the present study, we
combined endpoint flow cytometry with a noninvasive
bioluminescence imaging approach developed in our
laboratory [15] to study the effect of sublethal irradiation
on the dynamics of early and late donor cell engraftment
in immune-deficient mice.MATERIALS AND METHODS
Animals
Transgenic donor mice (Caliber Life Science,
Hopkinton,MA) andNOD/SCID/IL-2gc-/- recipients
(NSG) mice (Jackson Laboratories, Bar Harbor, ME)
were kept in separate pathogen-free facilities under ap-
proved protocols of the Children’s Hospital Los An-
geles Institutional Animal Care and Use Committee.BMT
Mononuclear bone marrow cells from FVB mice
(H-2Kq) ubiquitously expressing luciferase under theb-actin promoter were transplanted into 8- to 10-
week-old NSG recipients (H-2Kq). Recipients were
sublethally irradiatedwith a dose of 2.7Gy to thewhole
body (TBI) or locally to the right hind limb (RHL-IR)
before BMT. Whole bone marrow cells were injected
directly into the right or left femur (intrafemoral) or
i.v. through the tail vein using a 28-gauge needle.
Irradiation
TBIwasadministeredusingaMK-1-68Acesium-137
gamma animal irradiator (J.L. Shepherd & Associates,
SanFernando,CA) or aClinac 2100C6-MVX-ray linear
accelerator (VarianMedical Systems, Palo Alto, CA). Lo-
cal irradiation to the right hind limbwas accomplished by
placingthelimbsof theanesthetizedanimalwithinasingle
radiationfield encompassing the entire hind limb, includ-
ing the femoral head but not the pelvis. A 1.5-cm-thick
layer of artificial tissue was used to build up the dose to
the midplane of the leg to 2.7 Gy in a single dose. The
radiation dose at 0.5 cm outside the field border was
\10% of the central dose.
Flow Cytometric Analysis of Multilineage
Engraftment
Mice were euthanized at 3 days or 10-14 weeks af-
ter BMT by inhalation of a 75% CO2/25% O2 mix-
ture. Hematopoietic cells were harvested from the
left and right femurs, spleen, and peripheral blood of
each animal. Single-cell suspensions were stained in
1% fetal bovine serum in phosphate-buffered saline.
Flow cytometry data were acquired with a FACSCali-
bur flow cytometer (BD Bioscience, Franklin Lakes,
NJ) and analyzed using FlowJo software (Tree Star,
Inc., Ashland, OR). Cells were initially gated using
the forward and side-scatter distribution profile of
hematopoietic cells to eliminate any contribution
from debris, before analysis of donor chimerism by
monoclonal antibodies against mouse H-2Kq (BD
Pharmingen, San Diego, CA). Contribution of each
hematopoietic lineage was determined using CD11b
(monocyte), Ly-6c/g (granulocyte), CD33 (T cell),
B220 (B cell), and NK1.1 (NK cell) (BD Pharmingen).
Bioluminescence Imaging
Mice were imaged serially beginning 24 hours after
transplantation (day 1) as follows. A 125-mg/kg dose of
luciferin (Promega,Madison,WI) diluted inphosphate-
buffered saline was introduced by i.p. injection 8
minutes before imaging. Mice were anesthetized with
2%-3% isoflurane with oxygen in an induction cham-
ber, then placed into a Xenogen IVIS 100 imaging
system (Caliber Life Sciences) and maintained under
anesthesia during image acquisition. Acquisition time
began at 3 minutes each on the ventral and dorsal
surfacesof eachanimal andwasdecreased to1minute af-
ter 1 week and then to 1 second after 1month because of
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Living Image 2.5 software included with the imaging
system. With this software, regions of interest were
drawn around the whole body and the right and left
hind limbof eachmouse todetermine thedonor cell bio-
luminescence, measured in photons/second/cm2/stera-
dian. Negative control mice were injected with saline
solution instead of cells at the time of initial injection.
During imaging, negative controls were used to deter-
mine the threshold for detection of luciferase-specific
bioluminescence.
Statistical Analysis
Statistical analysis was performed with Prism soft-
ware (GraphPad Software, Inc, La Jolla, CA). Data are
presented as mean 6 standard error of the mean
(SEM). Before statistical analysis, data were trans-
formed logarithmically to allow the use of parametric
tests because of the small sample size of each group.
The unpaired t test was used for comparing 2 groups
of flow cytometry data. One-way analysis of variance
(ANOVA) using Bonferroni’s multiple-comparison
posttest was used for flow cytometry data with 3 or
more groups. Two-way ANOVA using Bonferroni’s
multiple-comparison posttest was used to analyze lon-
gitudinal bioluminescence data at each time point.
Early chimerism was analyzed by combining repeated
measurements for each animal within each group
for the first 10 days after BMT, followed by a paired
t test (for hind limb bioluminescence) or unpaired
t test (for whole-body bioluminescence). Late chime-
rism was analyzed by combining repeated measure-
ments for each animal within each group after 10
days post-BMT, followed by a paired t test (for hind
limb bioluminescence) or unpaired t test (for whole-
body bioluminescence).RESULTS
Sublethal TBI Increases Long-Term Donor
Chimerism
To evaluate the effect of sublethal irradiation on
donor cell engraftment, severely immune-deficient
mice underwent transplantation with a range of doses
of wild-type donor bone marrow cells in the presence
or absence of sublethal (2.7 Gy) TBI. Immune-
deficient mice were used as recipients to eliminate
any contribution of immune rejection from the process
of engraftment. At 14 weeks after BMT, recipient mice
were euthanized, and cells were harvested from bone
marrow, spleen, and peripheral blood to assess donor
cell chimerism by flow cytometry based on expression
of the donor major histocompatibility complex class I
type H-2Kq in recipient tissue (Figure 1).
Sublethal irradiation significantly increased donor
chimerism in the bone marrow compared with nonir-radiated recipients (69% 6 5%, compared with
6% 6 3% in mice receiving 1  106 donor cells;
P\.05) at 14 weeks after BMT (Figure 1A). As ex-
pected, in irradiated animals, the level of bone marrow
chimerism was correlated with cell dose; however, in
nonirradiated animals, bone marrow chimerism was
at equivalent low levels with all cell doses tested.
Reconstitution of all the hematopoietic lineages
from the donor cells was examined by flow cytometry
using antibodies against common mouse lineage
markers for macrophages, granulocytes, B cells, T cells,
andNKcells.Donor chimerism in thebonemarrowwas
predominantly from myeloid lineages (Figure 1A), and
irradiation mainly affected myeloid engraftment.
BMT with wild-type donor bone marrow restored the
predominantly lymphoid distribution of lineages in the
NSG spleen, all of which were, as expected, of donor
origin (Figure 1B). Based on the levels of donor chime-
rism and the lineage makeup of the chimerism, the do-
nor cells found to be circulating in the peripheral blood
presumably reflected the contributions from engraft-
ment of donor cells in the marrow and the subsequent
donor-derived lymphopoiesis in the immune-deficient
host thymus and spleen (Figure 1C). Thus, in the se-
verely immune-deficient host, sublethal irradiation sig-
nificantly increased long-term bonemarrow chimerism
predominantly of myeloid lineage.
Longitudinal Analysis of Donor Cell
Engraftment in Recipients with or without
Sublethal TBI Using Bioluminescence Imaging
To analyze the effects of sublethal irradiation on
the rate of engraftment, transgenic mice expressing
the firefly luciferase gene in all hematopoietic cells
were used as bone marrow donors. This permitted
the use of bioluminescence imaging to quantify rela-
tive levels of chimerism longitudinally at various time
points after BMT. Consistent with the flow cytometry
data shown in Figure 1, sublethal irradiation increased
long-term stable chimerism at all cell doses tested (1
106, P \.001; 1  105, P \.01; 1  104, P \.05)
(Figure 2A-2C). In contrast, early levels of donor chi-
merism (defined as days 1-10 post-BMT) rose rapidly,
reaching similar levels irrespective of whether or not
irradiation was given (Figure 2A-2C); only after the
first week was donor chimerism significantly
increased by irradiation. Irradiated and nonirradiated
recipients undergoing BMT at all cell doses had
significantly higher bioluminescence compared with
background levels in negative control (ie, nontrans-
planted) mice (Figure 2D and 2E).
Donor Chimerism During the Early
Posttransplantation Period
The finding of similar levels of bioluminescence
in the early posttransplantation period in irradiated
Figure 1. Sublethal irradiation increases long-term donor chimerism in bone marrow. Donor chimerism is shown as the percentage of H-2Kq–positive
donor cells (mean6 SEM) detected by flow cytometry in both femurs (A), spleen (B), and peripheral blood (C) of recipient mice at 14 weeks post-BMT.
Recipients received either no irradiation or a 2.7-Gy dose of TBI before i.v. injection of 1  106, 1  105, or 1  104 donor cells from whole bone
marrow. The shading pattern of each bar reflects the proportion of each lineage detected by flow cytometry for markers of macrophages/granulocytes
(gray), B cells (angled stripes), T cells (vertical stripes), NK cells (white), and ‘‘other’’ (ie, unclassified [black]) cells within the H-2Kq–positive population.
ANOVA with Bonferroni’s adjustment test (*P\.05) performed on logarithmic transformation of the data (in those groups with at least 2 mice) com-
bined from 3 experiments as follows: no irradiation (n5 2, n5 1 and n5 2 animals each) vs irradiation (n5 3, n5 2 and n5 1 animals each). Macs/grans
indicates macrophages/granulocytes; NK, natural killer.
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equivalent numbers of total donor cells regardless of
irradiation therapy. Because the limited sensitivity of
bioluminescence imaging might not allow for the de-
tection of differences in low levels of engraftment,
flow cytometric analysis was used to further analyze
the effects of irradiation on donor chimerism during
the early stages of engraftment. Again, immune-
deficient mice received either no irradiation or 2.7
Gy of TBI before receiving 1  106 wild-type bone
marrow cells i.v. from luciferase transgenic mice.
These recipients were sacrificed at 3 days or 7 days
post-BMT to assess total cell counts isolated from
the right femur using a hemacytometer. In addition
to bone marrow, cells from the spleen were harvested
from recipients 3 days post-BMT to assess donor cell
chimerism by flow cytometric analysis of H-2Kq–pos-
itive donor cells (Figure 3).
Sublethal TBI significantly decreased (P \.001)
the total number of cells (host plus donor) found in
the femurs of recipients at 3 days and 7 days post-
BMT (Figure 3A). Although the percentage ofdonor cells was increased in the femurs of irradiated
recipients compared with nonirradiated recipients at
3 days post-BMT (2.8% 6 0.2% vs 0.8% 6 0.1%;
Figure 3B), when the total cellularity was taken into ac-
count, the marrow of irradiated animals was found to
contain a lower number of donor cells than that of non-
irradiated animals (1.36 0.5  104 vs 8.26 1.5  104;
P 5 .002) (Figure 3C). In contrast, in the spleen, the
total number of donor cells did not differ significantly
between irradiated and nonirradiated recipients (6 6
2  104 vs 76 1  104; Figure 3D).Intrafemoral Injection Produces Lower
Long-Term Donor Chimerism in Bone
Marrow Than i.v. Administration of Donor Cells
in Sublethally Irradiated Immune-Deficient
Recipients
Several previous studies using xenogeneic trans-
plantation models have reported that purified human
stem cell and progenitor cell populations engraft
immune-deficient mice more efficiently when injected
Figure 2. Longitudinal analysis with bioluminescence imaging reveals a differential effect of sublethal irradiation on early versus late chimerism.Whole-
body bioluminescence was measured in recipient mice after i.v. BMTwith luciferase-expressing transgenic donor cells beginning 24 hours after BMTand
serially over the course of 96 days. Recipients received either no irradiation (NIR) or 2.7 Gy of TBI before i.v. injection of 1  106, 1  105, or 1  104
donor whole bone marrow cells. A, Logarithmic graph of mean6 SEM whole-body bioluminescence, measured in photons/second/cm2/steradian, plot-
ted against days after BMT in recipients of TBI (n 5 6) and nonirradiated mice (n 5 3), showing only those that received 1 106 donor cells. B, Log-
arithmic plot of mean6 SEMwhole-body bioluminescence of recipients of TBI (n5 2) and nonirradiated mice (n5 1), showing only those that received
1  105 donor cells. C, Logarithmic plot of mean 6 SEM whole-body bioluminescence in recipients of TBI (n 5 1) and nonirradiated mice (n 5 2),
showing only those that received 1  104 donor cells. Repeat bioluminescence measurements were combined for the first 10 days (early) or longer
than 10 days post-BMT (late) before the unpaired t test for statistical significance was used to compare TBI recipients and nonirradiated mice at
each cell dose (A-C). The P value for significance using the unpaired t test is given in each panel; NS indicates no statistical significance. TBI produced
significantly higher late (but not early) chimerism at each cell dose studied. D, Logarithmic plot of mean whole-body bioluminescence against days post-
BMT for all recipient groups. SEM is omitted for clarity. Data from control (nontransplanted) mice are shown in black, those from nonirradiated mice are
shown in blue, and data from mice receiving TBI are shown in red. Within each group, a solid line indicates a transplanted cell dose of 1  106 cells,
a dashed line represents a dose of 1  105 cells, and a dotted line represents a dose of 1  104 cells. Two-way ANOVA with Bonferroni’s multiple-
comparison posttest for statistical significance (*P\.05; **P\.01) was used to compare each recipient group versus controls (n 5 5) at each time
point. E, Representative images of donor cell bioluminescence in TBI, nonirradiated, and control recipient mice at 1, 4, 8, 14, and 96 days after BMT.
TBI and nonirradiated mice received a dose of 1  106 donor cells at BMT. In the right column, the images from each mouse at day 96 are scaled to
decrease the signal intensity and more clearly demonstrate the anatomic distribution of chimerism in the mice that received TBI. All statistical analyses
were performed on logarithmic transformation of the data combined from 3 experiments. NIR indicates no irradiation; NS, not statistically significant.
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Figure 3. Donor chimerism in the early posttransplantation period. Recipients received either no irradiation or a 2.7-Gy dose of TBI before i.v. injection
of 1  106 donor whole bone marrow cells. A, The total number of viable cells (mean 6 SEM) isolated from the right femur of sublethally irradiated
and nonirradiated mice was counted using a hemocytometer at 3 days and 7 days after BMT. B, Donor chimerism was determined as the percentage
(mean 6 SEM) of H-2Kq–positive donor cells detected by flow cytometry at 3 days post-BMT. The total number of donor cells (mean 6 SEM) was
calculated by multiplying the total cell count by the percentage of donor chimerism in the femur (C) and spleen (D) of recipient mice at 3 days post-
BMT. Data were analyzed using the unpaired t test for statistical significance comparing donor cell count and chimerism in irradiated and nonirradiated
recipients. Statistical analysis was performed on data from 5 mice per group from a single experiment. NS indicates not statistically significant.
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avoiding the problem of inefficient homing to
marrow through the i.v. route [16,17]. Thus, we
tested whether intrafemoral injection of whole
allogeneic bone marrow would also provide higher
levels of engraftment compared with i.v. infusion in
the sublethal irradiation setting. Surprisingly,
intrafemoral injection did not increase long-term chi-
merism based on fluorescence-activated cell sorting
(FACS) analysis of harvested tissues at 10 weeks post-
BMT (Figure 4). In fact, i.v. administration of donor
cells produced significantly higher systemic marrow
chimerism than that seen in animals given donor cells
via direct intrafemoral injection (69% 6 3% vs
40% 6 10%; P\.05; Figure 4A). Again, high levels
of donor chimerismwere seen in the spleen irrespective
of the route of administration (Figure 4B).
Bioluminescence imaging demonstrated that i.v.
infusion of donor marrow resulted in higher whole-
body signal levels compared with intrafemoral injec-
tion at almost all stages of engraftment, although
donor chimerism from intrafemoral administration
gradually increased to i.v. levels by 10 weeks post-
BMT (Figure 5A and 5B). Given that whole-body bio-
luminescence reflects donor cells, not only in the
marrow, but also in the spleen and peripheral blood,
local measurements of signal intensity in each hindlimb were then analyzed to compare the dynamics of
engraftment specifically in the marrow space with
each route of administration. In animals given i.v. do-
nor cell infusions, signal intensity was equivalent in
each hind limb at all time points (Figure 5C), as would
be expected with systemic administration. In animals
in which marrow was injected directly into the right
femur, early engraftment (up to 8 days) was higher in
the injected limb than in the noninjected limb, after
which time the signal intensity in both limbs increased
to similar levels (Figure 5D). These findings suggest
that mobilization of donor cells from the injected mar-
row and subsequent proliferation in distant sites delays
equilibration of chimerism in all marrow niches. Thus,
systemic chimerism increases more rapidly and effi-
ciently when donor cells are given i.v., because al-
though direct administration of donor cells into the
marrow cavity produces early efficient engraftment in
the local site of injection, redistribution to distal sites
is delayed.Sublethal TBI Produces Greater Long-Term
Chimerism Than Local Irradiation:
Intravenous BMT
A recent study found that local radiation increases
long-term stable engraftment in both irradiated and
Figure 4. Direct injection of donor cells into the bone marrow cavity does not improve long-term hematopoietic chimerism in sublethally irradiated
recipients. Donor chimerism is shown as %H-2Kq–positive donor cells detected by flow cytometry in the left and right femurs (A), spleen (B), and pe-
ripheral blood (C) of recipient mice at 10 weeks post-BMT. Recipients received 2.7 Gy of ionizing radiation before receiving 1 106 donor bonemarrow
cells injected i.v. (n5 3) or directly into the right femur (intra–right femoral [IF]; n5 3). Shown are mean6 SEM for the total percentage of donor cells,
with different hematopoietic lineages as described in Figure 1A. ANOVA with Bonferroni’s multiple-comparison posttest was used to determine the
statistical significance comparing chimerism in the left hind limb and the right hind limb within and between recipient groups. Left and right hind limb
data were combined and analyzed using the unpaired t test for statistical significance (*P \ .05) comparing systemic marrow engraftment in i.v.
versus intrafemoral BMT. Statistical analysis was performed on logarithmic transformation of data from one representative experiment. Macs/grans in-
dicates macrophages/granulocytes; NK, natural killer.
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However, this report did not address the question of
whether local irradiation can provide similar levels of
chimerism as that seen with TBI. Thus, we directly
compared engraftment patterns after local irradiation
of the right hind limb with those after TBI. After irra-
diation, recipients received luciferase-expressing do-
nor bone marrow cells via i.v. injection into the tail
vein, and chimerism was assessed as before by FACS
analysis of bone marrow at 10 weeks post-BMT and
longitudinally by bioluminescence imaging.
Donor chimerism was analyzed at 10 weeks post-
BMT by flow cytometry of cells isolated separately
from the right (irradiated) and left (nonirradiated)
hind limbs. With i.v. administration of donor marrow,
TBI provided significantly higher overall chimerism in
marrow from both hind limbs compared with local ir-
radiation of the right hind limb or no irradiation (TBI,
69% 6 3%; local irradiation, 7% 6 2%; no irradia-
tion, 6% 6 2%; P\ .001) (Figure 6A). As expected,
the nonirradiated and TBI-treated animals demon-
strated no difference in levels of chimerism betweenthe right hind limb and the left hind limb at 10 weeks
post-BMT. Animals that received local irradiation to
the right hind limb and i.v. marrow infusion showed
a trend toward higher chimerism in the irradiated
limb compared with the nonirradiated left limb at 10
weeks post-BMT (11%6 3% vs 4%6 1%), although
the differences did not reach statistical significance.
Bioluminescence imaging of the same animals
confirmed that after the first week post-BMT, sys-
temic (whole-body) chimerism, as measured by the
total bioluminescent signal of the whole animal, was
significantly greater in mice that received TBI com-
pared with mice that received either local irradiation
or no irradiation (Figure 6B). Consistent with our pre-
vious data, the significant increase in chimerism seen
with TBI was evident only after 7-10 days post-
BMT. Local irradiation conferred no increase in sys-
temic chimerism compared with no irradiation at
any time point; however, when imaging was restricted
to each hind limb, a significantly (P\ .05) higher sig-
nal was detected in the irradiated limb compared with
the nonirradiated limb, with the effect seen only after
Figure 5. Intrafemoral donor cell injection results in early local engraftment but delayed systemic engraftment compared with i.v. administration. Bio-
luminescence was measured serially in recipient mice after transplantation with transgenic donor marrow cells beginning at 24 hours post-BMT and
ending at 65 days post-BMT. Recipients received 2.7 Gy TBI before i.v. (IV-BMT; n 5 6) or intra–right femoral (RF-BMT; n 5 5) injection of 1  106
donor cells. A, Whole-body bioluminescence (mean 6 SEM) for all mice given IV-BMT (red) or RF-BMT (green). B, Representative images of donor
cell bioluminescence in recipient mice at days 1, 4, 8, 14, and 65 post-BMT frommice receiving IV-BMT (top) and RF-BMT (bottom). In the right column,
all images are scaled to decrease signal intensity and more clearly demonstrate the anatomic distribution of engraftment at 65 days post-BMT. C,
Bioluminescence signal (mean 6 SEM) gated on left (white) and right (solid red) hind limbs of IV-BMT recipients. (D) Bioluminescence signal
(mean 6 SEM) gated on left (white) and right (solid green) hind limbs after RF-BMT. In (A), repeated measurements of whole-body bioluminescence
were combined for the first 10 days (early) or for more than 10 days (late) post-BMT before applying the unpaired t test for statistical significance
(**P\.01; NS, not significant) comparing IV-BMT and RF-BMT. In (C) and (D), two-way ANOVA with Bonferroni’s multiple-comparison posttest for
statistical significance (*P\ .05) was used to compare bioluminescence in the left hind limb and the right hind limb of IV-BMT (C) and RF-BMT (D)
recipients at each time point. Statistical analyses were performed on logarithmic transformation of the data combined from 3 experiments.
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local irradiation was significantly inferior to TBI in
providing long-term chimerism after i.v. administra-
tion of bone marrow.
Sublethal TBI Produces Greater Long-Term
Chimerism Than Local Irradiation:
Intrafemoral BMT
To minimize any effect on homing, we next ex-
amined the effects of TBI versus local irradiation
when donor cells were injected directly into the mar-
row cavity. For locally irradiated animals, donor cells
were injected either into the irradiated (local) femoral
cavity or into the nonirradiated (distal) femoral cav-
ity. Again, donor chimerism at 10 weeks post-BMT
was analyzed separately by flow cytometry of cells
isolated from the right and left hind limbs. In all ex-
periments using intrafemoral BMT, TBI produced
significantly higher long-term marrow chimerism
compared with local irradiation applied to the in-jected or noninjected limb (40% 6 10% with TBI
vs 7% 6 3% with injection into the locally irradiated
femur [P\.05] and vs 4% 6 1% with injection into
the nonirradiated femur [P\.01]) (Figure 6C). Using
TBI, chimerism did not differ in injected and nonin-
jected limbs by 10 weeks post-BMT, consistent with
the data shown in Figure 4. When donor cells were
injected into the same (right) limb that had been
locally irradiated, the mean chimerism in the right
injected limb was higher than that in the left nonin-
jected, nonirradiated limb at 10 weeks post-BMT
(11% 6 5% vs 2% 6 1%), although these differences
did not reach statistical significance. When donor
cells were injected into the distal (left) limb that
had not been irradiated, the donor chimerism in
both limbs was no different from that seen in nonir-
radiated animals. Thus, a small effect was seen with
local irradiation only when bone marrow was infused
directly into the irradiated site, not when marrow was
infused distal to the irradiation.
Figure 6. Conditioning with TBI results in higher levels of chimerism compared with local marrow irradiation. Shown are the effects of local irradiation
and TBI and route of donor cell administration on long-term donor chimerism as measured by FACS analysis at 10 weeks post-BMT (A andC), and on the
dynamics of engraftment as measured by longitudinal bioluminescence imaging (B andD-G). Animals received no irradiation (NIR; A and B; n5 2), 2.7 Gy
of TBI (A and B; n 5 3), or 2.7 Gy of local irradiation to the right hind limb (RHL-IR) before i.v. (A, B, and E; n 5 3) or intrafemoral (C, D, F, and G)
administration of donor bone marrow. For animals that received either no irradiation (C and D; n 5 4) or TBI (C and D; n 5 5), intrafemoral admin-
istration was given into the right femur (RF-BMT). For animals that received local irradiation to the right hind limb, donor cells were injected either into
the irradiated right femur (RF-BMT; C, D, and F; n5 2) or into the nonirradiated left femur (LF-BMT; C, D, and G; n5 3). A and C, % H-2Kq–positive
donor cells detected by flow cytometry from samples analyzed separately from the left and right femurs of recipient mice at 10 weeks post-BMT.
ANOVA with Bonferroni’s adjustment test (***P \ .001) were used to compare the left hind limb and right hind limb within each group and
across each group. B and D, Logarithmic plots of mean whole-body bioluminescence versus days after i.v. (B) or intrafemoral BMT (D). Data for non-
irradiated mice are shown in blue with solid circles, data for mice receiving TBI are shown in red with solid circles, and data for mice receiving irradiation
to the right hind limb are shown with empty black circles with either a red line for right femur injection (RF-BMT) or a blue line for left femur injection
(LF-BMT). The nonirradiated and LF-BMT data overlap appears as a single blue line in the graph in (D). Two-way ANOVA with Bonferroni’s multiple-
comparison posttest for statistical significance (***P\.001) was used to compare each recipient group at each time point. E-G, To assess the dynamics of
engraftment in the marrow after local irradiation, the bioluminescence signal was measured after gating on the left or right hind limb region. Schemas of
experimental design are shown to the left of each set of data with i.v. donor cell injection (E), donor cell injection directly into the right irradiated femur
(F), and donor cell injection directly into the left (nonirradiated) femur (G). Repeated measurements of bioluminescence were combined for the first 10
days (early) or longer than 10 days (late) post-BMT before applying the paired t test for statistical significance (*P\.05, **P\.01 or NS, not significant)
comparing the left and right hind limbs in (E), (F), and (G). All statistical analyses were performed on logarithmic transformation of the data combined
from two experiments. IR, irradiation; macs/grans, macrophages/granulocytes; NK, natural killer; NS indicates not statistically significant.
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was consistent with endpoint analysis by FACS.
Donor chimerism after intrafemoral injection was
again significantly greater with TBI than with local
irradiation or no irradiation (Figure 6D). Again, the
bioluminescence signal was the same in all animals
during the first week post-BMT, with the benefits
of TBI becoming apparent only after day 8
(P \.001). No difference in overall chimerism be-
tween local irradiation and no irradiation was evident
(Figure 6D).Bioluminescence Imaging of Locally Irradiated
Mice Reveals That the Effects of Irradiation on
Hematopoietic Stem Cell Engraftment Are
Restricted to the Irradiated Site
Given our finding of high splenic chimerism with
and without irradiation, we hypothesized that splenic
engraftment would contribute to the whole-body bio-
luminescence signals seen in both nonirradiated and
locally irradiated mice (Figure 6B and 6D) and thus
might obscure chimerism differences specifically in
the marrow space. Consequently, we next analyzed
the signals arising from the right and left hind limbs
separately to assess whether local irradiation would
change the dynamics of engraftment specifically in
the marrow in the setting of i.v. administered donor
cells (Figure 6E) or injection of donor cells into the ir-
radiated (right) femur (Figure 6F) or the nonirradiated
(left) femur (Figure 6G). We were interested in exam-
ining whether radiation affected not only local engraft-
ment, but also the efficiency of migration to marrow
distal to the injection site.
As mentioned earlier, local irradiation had no ef-
fect on early donor chimerism in the marrow after
i.v. infusion, as demonstrated by identical signals
from irradiated and nonirradiated hind limbs during
the first week post-BMT (Figure 6E). However, a sig-
nificantly higher (P\.05) signal was detected from the
irradiated limb compared with the nonirradiated limb
after 1 week (Figure 6E).
When bone marrow was injected locally, the sig-
nal was statistically higher in the injected limb during
the first week post-BMT irrespective of whether the
limb injected was on the side that received irradiation
(Figure 6F; P\.05) or on the side contralateral to ir-
radiation (Figure 6G; P\.01). The higher initial do-
nor chimerism in the injected sites was maintained
into the later posttransplantation period; however,
long-term donor chimerism was greatest in the limbs
that received donor cells injected into the irradiated
sites. These findings lead us to conclude that the ef-
fects of local sublethal irradiation are limited to the
irradiated microenvironment rather than induction
of systemic factors that can influence distal sites of
engraftment.DISCUSSION
The clinical use of nonmyeloablative preparative
regimens for hematopoietic stem cell transplantation
continues to increase since the first observations that
donor chimerism could be accomplished with signifi-
cantly reduced toxicity to the recipient. Most of these
regimens combine low-dose irradiation, as either TBI
or total lymphoid irradiation, with lymphoablative
drugs. How low-dose irradiation improves engraft-
ment is not clear, but the main mechanism for this
effect is thought to be an increase in host lymphoabla-
tion and consequent prevention of immunologic rejec-
tion. However, some experimental models suggest that
sublethal irradiation improves stem cell engraftment
through effects on the marrow microenvironment in
a dose-dependent manner [18]. To examine the effects
of low-dose irradiation on nonimmunologic mecha-
nisms of engraftment, we analyzed the kinetics of do-
nor engraftment in severely immune-deficient mouse
recipients. We found that sublethal TBI significantly
increased marrow engraftment after allogeneic BMT
independent of any effects on lymphoablation.
The use of bioluminescence imaging revealed that
although long-term chimerism is increased by suble-
thal irradiation, this effect is not a result of increased
early engraftment. The increased percentage of donor
cells in irradiated bone marrow early post-BMT de-
tected by flow cytometry reflects the rapid loss
of host cells after irradiation. In fact, early post
BMT, irradiation reduced, rather than increased, the
absolute number of donor cells in the host bone mar-
row. This finding is consistent with the results of pre-
vious studies comparing homing and engraftment of
donor cells in nonirradiated and lethally irradiated
transplant recipients [17,19,20]. Damage to stromal
cells after irradiation has been shown to decrease the
retention of hematopoietic cells in the bone marrow,
leading to increased lodgment of donor cells in
nonhematopoietic organs, such as the liver, lung, and
skeletal muscle, after transplantation [20,21]. This
might explain the equivalent whole-body biolumines-
cence seen in our imaging studies of irradiated andnon-
irradiated recipients during the first week post-BMT.
Bioluminescence imaging revealed that expansion
of donor cells began 7 days after engraftment and
continued for approximately 30 days after BMT.
This late expansion was significantly increased with
sublethal irradiation. These findings are consistent
with the hypothesis that irradiation induces changes
in the recipient marrowmicroenvironment that stimu-
late donor cell expansion rather than facilitate homing.
The finding that local irradiation enhanced long-term
chimerism of the irradiated limb, but not of distal sites,
suggests that the effect of radiation is limited to the lo-
cal irradiated microenvironment and is not due to the
release of systemic factors. Of note, even in animals
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duced higher levels of overall marrow chimerism com-
pared with local irradiation, presumably because of the
larger area of marrow space affected by TBI.
Intrafemoral transplantation has been reported to
improve engraftment comparedwith i.v. transplantation
in allogeneic [22] and xenogeneic BMT models
[5,22,23]. However, in the present study, we found
that i.v. administration of donor cells produced higher
levels of marrow chimerism than intrafemoral
administration. Several aspects of our experimental
design might explain the discrepancies between our
findings and previous reports. Almost all of the data
comparing intrafemoral and i.v. transplantation used
small numbers of purified human stem and progenitor
cells transplanted into immune-deficientmice [5,24-26].
It is likely that homing in the xenogeneic model is
relatively inefficient, and that direct administration
into the marrow space provides an advantage over
systemic infusion in the xenogeneic setting. In
addition, depletion of T cells and other mature cells
from the more purified stem cell grafts used in the
previous studies would be expected to further reduce
the efficiency of homing and engraftment. In our
study, we used unfractionated allogeneic bone marrow
rather than purified stem cells, thereby possibly further
facilitating engraftment in the i.v. transplantations.
Because whole-body bioluminescence imaging re-
flects a composite of donor cells circulating from mar-
row to other lymphohematopoietic organs, we also
performed bioluminescence analysis of hind limbs sep-
arately to assess chimerism specifically in each marrow
space. In mice given TBI, the signal from donor cells
was higher at the injected site than in distal sites during
the first week post-BMT. However, after the first
week, locally injected cells hadmobilized to and prolif-
erated in distant sites, eventually leading to long-term
systemic chimerism. Thus, although locally injected
limbs had high levels of chimerism initially, engraft-
ment at distal sites was delayed compared with that
in mice receiving i.v. transplantation.
An interesting study by Ito et al. [10] found that an-
imals receiving locally delivered sublethal irradiation to
themediastinum or hind limbs alone had increased do-
nor chimerism in local and distal sites compared with
animals that received no irradiation. The authors sug-
gested that their data supported a model in which local
irradiation first induces local proliferation of engrafted
donor cells at irradiated sites, which subsequently
equilibrate systemically to increase chimerism in non-
irradiated sites. That study involved only i.v. adminis-
tration of donor cells, and thus did not address how
cells would respond if injected directly into the irradi-
ated or nonirradiated marrow spaces.
We found that regardless of the injection route, re-
cipients with 2.7 Gy delivered as TBI had significantly
higher long-term systemic engraftment comparedwith recipients receiving 2.7 Gy of local irradiation re-
stricted to the right hind limb. However, again there
was no difference in early whole-body biolumines-
cence in recipients of TBI, local irradiation, and no ir-
radiation. It should be noted that several differences in
the experimental design between the study of Ito et al.
[10] and the present study might account for the
greater effect of local irradiation seen in the former
study. Ito et al. used both a higher radiation dose
(7 Gy) and a larger exposure area than our study (me-
diastinal was estimated as 20% of the total marrow
space, compared with 7.5% for a single limb, based
on data by DR Boggs [27]. In addition, they used
a 200-fold higher cell dose than that used in our study.
In summary, the highest levels of long-term chi-
merism were seen with the combination of TBI and
i.v. administration of donor cells. The effect of suble-
thal irradiation was first detected at least 1 week post-
BMT; during the first week, bioluminescence was
unaffected by either systemic or local irradiation.
These findings indicate that sublethal irradiation
most likely increases long-term chimerism through
direct effects on the marrow microenvironment that
induce proliferation of donor cells, an effect that is en-
hanced by both systemic administration of donor cells
and maximization of the area of irradiation.ACKNOWLEDGMENTS
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